About BeneChill
BeneChill is a company based in San Diego (United States) founded in 2004 was acquired by BrainCool in October 2016. BeneChill has raised $41.6 million across 6 funding rounds from investors including BrainCool, MedVenture Associates and NGN Capital. The company has 9 employees as of December 31, 2015. BeneChill operates in a competitive market with competitors including Attune Medical, ZOLL AEDs, Inspiration Healthcare, InnAccel and Glucoset, among others.
- Headquarter San Diego, United States
- Employees 9 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Benechill, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BeneChill
BeneChill has successfully raised a total of $41.6M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $6.57 million completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BeneChill
BeneChill has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include BrainCool, MedVenture Associates and NGN Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences sector focused VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
NGN Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for BeneChill
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BeneChill
Investment portfolio details for BeneChill
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BeneChill
Detailed financials for BeneChill
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Benechill Comparisons
Peer comparison for BeneChill
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BeneChill
BeneChill operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Attune Medical, ZOLL AEDs, Inspiration Healthcare, InnAccel and Glucoset, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient temperature is modulated via esophageal cooling devices.
|
|
| Locked | Locked | Locked |
Medical devices and software for emergency care are developed.
|
|
| Locked | Locked | Locked |
Medical devices for intensive care units are developed.
|
|
| Locked | Locked | Locked |
Diversified medical devices are manufactured for critical and maternal care.
|
|
| Locked | Locked | Locked |
Continuous intravascular blood glucose monitoring devices are developed.
|
|
| Locked | Locked | Locked |
Brain cooling technologies and therapeutic hypothermia devices are developed.
|
Detailed competitors of BeneChill
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Benechill
Complete news archive for BeneChill
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BeneChill
BeneChill was founded in 2004 and raised its 1st funding round 3 years after it was founded.
BeneChill is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
BeneChill is a funded company, having raised a total of $41.6M across 6 funding rounds to date.
As of Dec 31, 2015, the latest employee count at BeneChill is 9.
BeneChill was founded in 2004 in San Diego, United States. Non-invasive cooling technologies are developed to address acute ischemic events, including cardiac arrest, stroke, and traumatic brain injury. The RhinoChill System is employed to lower patient body temperature. Operations are based in the medical device sector, with offices maintained in San Diego and Wallisellen, Switzerland.
BeneChill's top competitors include ZOLL AEDs, Inspiration Healthcare and InnAccel.
BeneChill has 5 investors. Key investors include BrainCool, MedVenture Associates, NGN Capital, Healthcap, and Solon Foundation.